Quick Answer
PharmaCyte Biotech, Inc. reported Net Income of $30.66 million for fiscal year 2025.
PharmaCyte Biotech, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $30.66M | +9085.0% |
| 2024 | $333.8K | +107.7% |
| 2023 | -$4.32M | -1.8% |
| 2022 | -$4.24M | -19.4% |
| 2021 | -$3.55M | +7.2% |
| 2020 | -$3.83M | +5.9% |
| 2019 | -$4.07M | +40.4% |
| 2018 | -$6.83M | -53.7% |
| 2017 | -$4.44M | +26.7% |
| 2016 | -$6.06M | +38.9% |
| 2015 | -$9.93M | +63.6% |
| 2014 | -$27.25M | -1605.4% |
| 2013 | -$1.60M | +15.9% |
| 2012 | -$1.90M | -35.9% |
| 2011 | -$1.40M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $746.9K | +124.5% | +110.1% |
| October 31, 2025 | -$7.42M | -404.8% | +11.3% |
| July 31, 2025 | -$8.36M | -135.7% | -174.5% |
| January 31, 2025 | -$3.05M | -391.5% | -107.2% |
| October 31, 2024 | -$1.47M | -152.7% | -106.3% |
| July 31, 2024 | $23.42M | +835.8% | +3880.5% |
| January 31, 2024 | -$619.5K | +18.9% | -122.2% |
| October 31, 2023 | $2.79M | +248.4% | +187.6% |
- PharmaCyte Biotech, Inc. showed an increase of +9085.0% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, PharmaCyte Biotech, Inc.’s net income has grown by 2293.3% (from -$1.40 million to $30.66 million).
- The most recent figure is from PharmaCyte Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 11, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: